問卷

TPIDB > Search Result

Search Result

篩選

List

18Cases

2017-01-01 - 2028-12-31

Phase II

Active
A Phase II, Dose-randomization, Open-label Study to Assess the Safety and Efficacy of PTS100 in Primary Hepatocellular Carcinoma Patients Who Are Ineligible for Operation or Current Locoregional Therapy (OASES)
  • Condition/Disease

    Hepatocellular Carcinoma

  • Test Drug

    Para-Toluenesulfonamide (PTS)

Participate Sites
6Sites

Recruiting5Sites

Terminated1Sites

2025-03-01 - 2027-02-28

Phase I

Active
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Recruiting2Sites

2021-02-01 - 2026-03-18

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
10Sites

Not yet recruiting2Sites

Recruiting7Sites

Terminated1Sites

2022-09-01 - 2024-12-20

Phase I

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Recruiting4Sites

2020-10-26 - 2024-10-01

Phase I

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
9Sites

Recruiting6Sites

Terminated2Sites

2020-04-01 - 2028-12-31

Phase I/II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Recruiting6Sites

2022-11-18 - 2027-12-31

Phase I

Active
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Recruiting7Sites

2022-05-01 - 2026-01-11

Phase II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
10Sites

Recruiting10Sites

2019-12-20 - 2026-12-31

Others

Active
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Recruiting2Sites

2022-01-01 - 2024-07-31

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
11Sites

Recruiting11Sites

1 2